Tribio Anti-Human CD38 & CD3E Bispecific Antibody (TBS10422)

Description

Description: Tribio CD38 & CD3E Bispecific Antibody is a modified antibody that binds CD38 on tumor cells and CD3E on T cells at the same time. It helps recruit and activate T cells to directly recognize and kill CD38-positive cells. This makes it widely used in cancer immunotherapy research, especially for studying multiple myeloma and other CD38-expressing hematologic malignancies.

Applications: ELISA, Bioactivity: FACS, Functional assay, Research in vivo

Species reactivity: Human

Host species: Human

Target: Cyclic ADP-ribose hydrolase 1, ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1, cADPr hydrolase 1, 2′-phospho-ADP-ribosyl cyclase/2′-phospho-cyclic-ADP-ribose transferase, T10, 2′-phospho-cyclic-ADP-ribose transferase, CD38, ADPRC 1, ADP-ribosyl cyclase 1, 2′-phospho-ADP-ribosyl cyclase, T3E, T-cell surface antigen T3/Leu-4 epsilon chain, CD3e, CD3E, T-cell surface glycoprotein CD3 epsilon chain

Isotype: half-IG G1 – kappa / (scFv – heavy – lambda) -h-CH2-CH3

Accession/UniProt: P28907 & P07766

Concentration: 3 mg/ml

Purity: >95%

Formulation: Liquid

Storage buffer: 0.01M PBS, pH 7.4

Purification: Protein A/G purified from cell culture supernatant.

Clonality: Monoclonal

Storage: Avoid repeated freeze-thaw cycles. -20°C for 12 months; -80°C for long-term storage.

Research use only.

Additional information